Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Relay Therapeutics Inc (NASDAQ: RLAY) was $6.16 for the day, down -0.65% from the previous closing price of $6.20. In other words, the price has decreased by -$0.65 from its previous closing price. On the day, 1.13 million shares were traded. RLAY stock price reached its highest trading level at $6.39 during the session, while it also had its lowest trading level at $6.1.
Ratios:
Our analysis of RLAY’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 18.42 and its Current Ratio is at 18.42. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on September 10, 2024, Upgraded its rating to Buy and sets its target price to $16 from $10.60 previously.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 28 ’24 when Rahmer Peter sold 1,621 shares for $6.06 per share. The transaction valued at 9,823 led to the insider holds 390,063 shares of the business.
Catinazzo Thomas sold 6,802 shares of RLAY for $41,220 on Oct 28 ’24. The Chief Financial Officer now owns 306,391 shares after completing the transaction at $6.06 per share. On Oct 29 ’24, another insider, Catinazzo Thomas, who serves as the Chief Financial Officer of the company, sold 2,300 shares for $5.95 each. As a result, the insider received 13,685 and left with 304,091 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 1031079296 and an Enterprise Value of 241285024. For the stock, the TTM Price-to-Sale (P/S) ratio is 104.01 while its Price-to-Book (P/B) ratio in mrq is 1.23. Its current Enterprise Value per Revenue stands at 24.114 whereas that against EBITDA is -0.62.
Stock Price History:
Over the past 52 weeks, RLAY has reached a high of $12.14, while it has fallen to a 52-week low of $5.60. The 50-Day Moving Average of the stock is -9.08%, while the 200-Day Moving Average is calculated to be -17.71%.
Shares Statistics:
RLAY traded an average of 1.97M shares per day over the past three months and 1456980 shares per day over the past ten days. A total of 127.46M shares are outstanding, with a floating share count of 124.33M. Insiders hold about 25.72% of the company’s shares, while institutions hold 55.84% stake in the company. Shares short for RLAY as of 1728950400 were 11855809 with a Short Ratio of 6.03, compared to 1726185600 on 9924227. Therefore, it implies a Short% of Shares Outstanding of 11855809 and a Short% of Float of 8.9099996.
